TWD 19.65
(-0.51%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 295.82 Million TWD | -10.8% |
2022 | 381.79 Million TWD | 27.57% |
2021 | 299.28 Million TWD | 54.09% |
2020 | 194.22 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 289.03 Million TWD | 291.93% |
2024 Q2 | 47.78 Million TWD | -83.47% |
2023 Q3 | 73.74 Million TWD | 4.21% |
2023 FY | 340.54 Million TWD | -10.8% |
2023 Q4 | 73.74 Million TWD | 0.0% |
2023 Q2 | 70.77 Million TWD | 0.0% |
2023 Q1 | 70.77 Million TWD | -2.16% |
2022 FY | 381.79 Million TWD | 27.57% |
2022 Q4 | 72.33 Million TWD | 0.0% |
2021 FY | 299.28 Million TWD | 54.09% |
2020 FY | 194.22 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Lytone Enterprise, Inc. | 42.08 Million TWD | -602.947% |
Vetnostrum Animal Health Co., Ltd. | 114.9 Million TWD | -157.46% |